Structural Proteomics

Program

• • Poster presentation
  • P-II-0559

  LiP-MS guided drug discovery using the cancer driver Ras as a model system

  • Foroughsadat Absar (Montreal / CA)

   Structural Proteomics
• • Poster presentation
  • P-II-0561

  Aggrescan4D: structure-informed analysis of pH-dependent protein aggregation

  • Oriol Bárcenas (Bellaterra / ES)

   Structural Proteomics
• • Poster presentation
  • P-II-0562

  Don't waste time – ensure success in your cross-linking mass spectrometry experiments before you begin

  • Julia Chamot-Rooke (Paris / DE)

   Structural Proteomics
• • Poster presentation
  • P-II-0563

  Structural analysis of a plant glucosyl ceramidase (GBA2)-like enzyme from arabidopsis thaliana by cryogenic electron microscopy (CRYO-EM)

  • Sunaree Choknud (Nakhon Ratchasima / TH)

   Structural Proteomics
• • Poster presentation
  • P-II-0564

  Natural inhibitors of snake venom toxins: a promising source of therapeutic peptides for toxin-centric next-generation antivenoms

  • Ana Gisele da Costa Neves Ferreira (Rio de Janeiro / BR)

   Structural Proteomics
• • Poster presentation
  • P-II-0565

  Optimized XL-MS workflows for heterobifunctional crosslinkers SDA and DizSEC

  • Yi He (San Jose, CA / US)

   Structural Proteomics
• • Poster presentation
  • P-II-0566

  Protein–RNA crosslinking combined with MS becomes quantitative at the peptide and amino-acid level

  • Daniel Hermanson (San Jose, CA / US)

   Structural Proteomics
• • Poster presentation
  • P-II-0567

  The regulation role of host cell calmodulin in late phase of retroviral life cycle

  • Petra Junková (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0568

  A novel cross-linking strategy for aromatic residues

  • Michael Karpisek (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0569

  Fast FluoroAlkylation of Proteins (FFAP) as a new tool for characterization of protein therapeutics

  • Zdenek Kukacka (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0570

  Quantitative assessment of protein structural changes and drug binding affinities using limited proteolysis mass spectrometry

  • Namgil Lee (Seoul / KR)

   Structural Proteomics
• • Poster presentation
  • P-II-0571

  Fast photochemical oxidation of protein: DIA workflow and the impact of the peptide identification framework

  • Dmitry Loginov (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0572

  Structural proteomics of human serum proteins

  • Petr Man (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0573

  Unveiling hidden protein dynamics: a multi-proteomic approach to study new players in metastatic melanoma progression

  • Alessandra Morelli (Milan / IT)

   Structural Proteomics
• • Poster presentation
  • P-II-0574

  Trapped-ion mobility spectrometry with PASEF for analysis of RNA-protein crosslinks in Escherichia coli ribosomes and HeLa cell line nucleic extract

  • Sergey Moshkovskiy (Goettingen / DE)

   Structural Proteomics
• • Poster presentation
  • P-II-0575

  Determination of M-PMV matrix protein-calmodulin interaction interface using hydrogen deuterium exchange mass spectrometry

  • Tereza Nesporova (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0576

  Investigation of protein dynamics in immortalized mouse macrophages stimulated by lipopolysaccharide (LPS) using limited proteolysis-coupled mass spectrometry

  • Aleksandra Nita-Lazar (Bethesda, MD / US)

   Structural Proteomics
• • Poster presentation
  • P-II-0577

  A novel opportunities for the structural characterization of the biomolecular assemblies

  • Petr Novák (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0578

  Novel, specific protein structural biomarkers for Alzheimer's disease and dementia with Lewy bodies

  • Anna Pagotto (Zurich / CH)

   Structural Proteomics
• • Poster presentation
  • P-II-0579

  In silico identification of potential inhibitors against Galectin-3-Binding Protein: A potent Key factor for glioma progression

  • Rashmi Rana (New Delhi / IN)

   Structural Proteomics
• • Poster presentation
  • P-II-0580

  Use of singlet oxygen to analyze protein structure

  • Jan Rasl (Prague / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0581

  Advancements in LiP-MS: short-gradient LC-MS and automated sample preparation for improved drug target identification

  • Luca Räss (Schlieren / CH)

   Structural Proteomics
• • Poster presentation
  • P-II-0582

  A multi-proteomics approach identifies non-catalytic effects of ATP-competitive kinase inhibition

  • Viviane Reber (Zurich / CH)

   Structural Proteomics
• • Poster presentation
  • P-II-0583

  Deep proteomics reveals incorporation of unedited proteins into mitochondrial protein complexes in Arabidopsis

  • Nils Rugen (Hannover / DE)

   Structural Proteomics
• • Poster presentation
  • P-II-0585

  Comparison of different glycoproteomics software of glycoproteomics including GRable, a new web-based software using a MS1-based glycopeptide detection method

  • Hiroaki Sakaue (Tsukuba / JP)

   Structural Proteomics
• • Poster presentation
  • P-II-0586

  Photo-crosslinked peptide-RNA hybrids with tunable length map protein-RNA interfaces across the proteome and transcriptome

  • Shuyao Sha (Freising / DE)

   Structural Proteomics
• • Poster presentation
  • P-II-0587

  Advancing Crosslinking Mass Spectrometry: Integrating Novel Data Acquisition Strategies and Enhanced Work-Up Techniques

  • Barbara Steigenberger (Munich / DE)

   Structural Proteomics
• • Poster presentation
  • P-II-0588

  Multimodal mass spectrometry identifies a conserved protective epitope in S. pyogenes Streptolysin O

  • Di Tang (Lund / SE)

   Structural Proteomics
• • Poster presentation
  • P-II-0589

  A structural proteomics approach to quantify protein reorganization during TDP-43 liquid-to-solid phase transitions

  • Federico Uliana (Mainz / DE)

   Structural Proteomics
• • Poster presentation
  • P-II-0590

  Structure and interactions of the endogenous human commander complex

  • Markku Varjosalo (Helsinki / FI)

   Structural Proteomics
• • Poster presentation
  • P-II-0591

  Structural proteomics for the development of thrombolytic drug

  • Naina Verma (Brno / CZ)

   Structural Proteomics
• • Poster presentation
  • P-II-0592

  Novel XL-MS analysis workflows for membrane protein characterization

  • Rosa Viner (San Jose, CA / US)

   Structural Proteomics
• • Poster presentation
  • P-II-0593

  In vivo protein footprinting reveals the dynamic conformational changes of Proteome of multiple tissues in progressing Alzheimer's disease

  • John Yates (La Jolla, CA / US)

   Structural Proteomics
• • Poster presentation
  • P-II-0594

  Structural mass spectrometry captures residue-resolved comprehensive conformational rearrangements of a G protein-coupled receptor

  • Bingjie Zhang (Shanghai / CN)

   Structural Proteomics